10th Biennial Symposium of the International Eosinophil Society, Inc.

会议摘要 R13会议支持请求第10届两年一次的嗜酸性粒细胞研讨会-“嗜酸性粒细胞2017”， 2017年7月19日至23日在瑞典哥德堡的Elite Park Avenue酒店举行， 国际嗜酸性粒细胞学会(IES)（www.eosinophil-society.org）中找到。会议将邀请~30名 演讲者和约150名提交摘要的额外参与者。一个尖端的程序， 基础、转化和临床研究已由当地组织委员会协商准备 与IES的科学计划委员会。该计划将包括会议：（1）嗜酸性粒细胞在主机- 寄生虫的相互作用，（2）嗜酸性粒细胞在胃肠道健康和疾病，3）嗜酸性粒细胞的作用， 代谢调节，（4）过敏和超敏反应中的嗜酸性粒细胞，（5）先天性，适应性和 自身免疫，（5）嗜酸性粒细胞诊断和治疗生物标志物，6）嗜酸性粒细胞发育的调节， 招募和生存，7）嗜酸性粒细胞组学，8）嗜酸性粒细胞和微生物组学，以及9）针对初级 研究嗜酸性粒细胞的方法和资源。本次会议的目标是提供一个 高度互动的跨学科论坛，供青年科学家和资深科学家进行科学交流， 过敏、免疫学、微生物学、血液学和癌症领域与嗜酸性粒细胞在 健康和疾病。一个主要目标是汇集在嗜酸性粒细胞生物学方面具有专业知识的基础科学家， 以及对嗜酸性粒细胞相关疾病感兴趣的临床研究人员，以提高对疾病的理解 机制，嗜酸性粒细胞功能的意义，并促进转化研究。第二个目标是 促进年轻调查人员的发展和兴趣，以帮助支持他们的职业生涯，创造一个新的 产生“嗜酸性粒细胞”。为了实现这一点，会议有一个类似于Keystone的结构，所有与会者都参加了会议。 在一个单一的场所，在同一个基础上分享膳食和住宿，鼓励非正式的互动。 通过科学和社会计划，将强调创造一个全球社区， 嗜酸性粒细胞科学家这次会议将是特别及时的，因为数据从目前的临床试验新的 直接或间接阻断嗜酸性粒细胞介导的炎症通路的生物疗法， 为嗜酸性粒细胞在人类健康和疾病中的作用提供了明确的数据。研讨会，其 非常重视跨学科研究，涵盖重要的全球性疾病，包括哮喘，嗜酸性粒细胞增多症， 食管炎、寄生虫病和嗜酸性粒细胞增多综合征。研讨会由全体会议和 海报会议，全体会议结合了该领域领导人的最新会谈和切割 边缘讲座最近高影响力的研究，并包括从提交的摘要选择口头报告。 两个海报会议具有高度优先地位，没有人反对，并包括“图尔斯参观”影响力大的研究。我们有 两个奖项讲座，第七届埃利希奖的科学家谁作出了重大的全面贡献的领域， 以及Gleich奖，授予在过去两年中发表了最具影响力论文的科学家。

CONFERENCE ABSTRACT R13 conference support is requested for the 10th Biennial Eosinophil Symposium – “Eosinophils 2017”, to be held from 19-23 July 2017 at the Elite Park Avenue Hotel, Gothenburg, Sweden, under the auspices of the International Eosinophil Society, Inc. (IES) (www.eosinophil-society.org). The meeting will host ~30 invited speakers and ~150 additional participants who submit abstracts for presentation. A cutting edge program of basic, translational and clinical research has been prepared by the Local Organizing Committee in consultation with the Scientific Program Committee of IES. The program will include sessions on: (1) eosinophils in host- parasite interactions, (2) eosinophils in gastrointestinal tract health and disease, 3) roles of eosinophils in metabolic regulation, (4) eosinophils in allergy and hypersensitivity, (5) eosinophils in innate, adaptive and autoimmunity, (5) eosinophil diagnostic and therapeutic biomarkers, 6) regulation of eosinophil development, recruitment and survival, 7) eosinophilomics, 8) eosinophils and microbiomes, and 9) a session targeting junior investigators on methods and resources for studying eosinophils. The goal of this conference is to provide a highly interactive, interdisciplinary forum for scientific exchange amongst junior and established scientists in the fields of allergy, immunology, microbiology, hematology and cancer in relation to the roles of eosinophils in health and disease. A primary objective is to bring together basic scientists with expertise in eosinophil biology, and clinician investigators interested in eosinophil-associated diseases, to improve understanding of disease mechanisms, significance of eosinophil functions, and foster translational research. A second objective is to foster the development and interests of younger investigators to help support their careers, creating a new generation of “eosinophiles”. To accomplish this, the meeting has a Keystone-like-structure with all participants in a single venue, sharing meals and accommodations on the same footing, encouraging informal interactions. There will be an emphasis through both the scientific and social programs on creating a global community for eosinophil scientists. This meeting will be particularly timely because data from current clinical trials of new biological therapies, which directly or indirectly block eosinophil-mediated inflammatory pathways, are now providing definitive data on the roles of eosinophils in human health and disease. The symposium, with its strong emphasis on inter-disciplinary research, covers important global diseases including asthma, eosinophilic esophagitis, parasitic diseases and hypereosinophilic syndromes. The symposium consists of plenary and poster sessions, with plenary sessions combining state-of-the-art talks from leaders in the field with cutting edge lectures on recent high impact studies, and include oral presentations selected from submitted abstracts. Two poster sessions have high priority, are unopposed and include “tours” of high-impact studies. We have two prize lectures, the 7th Ehrlich award for the scientist who has made a major overall contribution to the field, and the Gleich award for the scientist with the highest impact paper published over the previous two years.